The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology. (2022)

First Author: Tamborero D

Attributed to: `Analysis of neo-antigens and immune profiles of Asian breast cancer patients, focusing on common germline deletion of APOBEC3B cytosine deaminase funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.17863/cam.81927

Publication URI: https://www.repository.cam.ac.uk/handle/1810/334509

Type: Journal Article/Review